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are well referenced and indexed, and dis-
cussions are included. The presentation ofthe
book is ofa highstandard and isrecommended
as a detailed and comprehensive treatise on
the use of tissue temperature in diagnosis
and in therapy. It is unlikely to be bettered
until many of the problems discussed have
been largely solved.
J. HENDRY
Long Term and Short Term Screening
Assays for Carcinogens: A Critical
Appraisal. IARC PUBLICATION REPORTS.
(1980). Geneva: WHO. 426 pp. 40 Sw. Fr.
This is definitely one of the more worth-
while appraisals in this series and offers an
acceptable foundation for anyone entering
the field of carcinogen screening and a useful
reference source for those already in the
field.
The first report is concerned with long-
term assays, and details practically every pit-
fall of such systems. This is so important in
assay systems which have so many inherent
variables. Everything from the administra-
tion of the test substance, through animal
caging/bedding selection, to processing of
the data is discussed.
The reports on 'Mutagenesis Assays in
Bacteria', 'Mutagenesis Assays in Mamma-
lian Cells', 'Transformation in Cell Culture'
and 'Cytogenetic Damage as an end point in
short-term Assay systems' are well and
enthusiastically presented, detailing the ad-
vatages and dis-advantages ofboth, the parti-
cular class of screening test and the detailed
and varied methods encompassed withineach
class.
Perhaps the most interesting report in the
book is that on 'Mutagenesis Assays with
Whole Mammals'. This is an area that has
been relatively poorly studied and theoreti-
cally represents the situation closest to that
in real life. Conversely, the Yeast, Drosophila
andDNA-repair chapters tend todemonstrate
that these areas are outmoded.
A. KINSELLA
The Occurence of Tumours in Domestic
Animals (NEI Monograph 54). W. A.
PRIESTNER and F. W. McKAY. Bethesda:
National Institutes of Health. 210 pp.
U.S. $8.50.
The expectation that research into neo-
plasia in domestic animals would provide
new insight into the origins of human cancer,
led to the establishment in 1961 of the
Epizoology Section within the Epidemiology
branch of the National Cancer Institute.
Data from 15 veterinary schools in the
U.S.A. and Canada have been processed
at the National Cancer Institute and the
details on neoplastic disease are published in
the present volume.
Neoplasms in cats were mainly malig-
nant (88%) and horses had the lowest
proportion of malignant tumours (400o) with
dogs (56%) and cattle (770o) intermediate.
The tumours most commonly seen were:
Cattle; squamous-cell carcinoma, lym-
phoma, leukaemia.
Horse; squamous-cell carcinoma, malig-
nat melanoma, fibrosarcoma.
Cat and Dog; tumours of the skin, haemo-
poetic and lymphatic tissues, and mammary
gland
In many cases the R (summary relative
risk) values are given. For all tumours in
dogs the Boxer had R 3-4 and the St. Bernard
3 0. The Pekinese R value was 0-2 for the
Beagle (commonly used for carcinogen test-
ing) R was 09. High R values in osteosarco-
mas were seen in the St. Bernard (10.9) and
Gt. Dane (7.9), whereas in the Chihuahua it
it was 01.
For canine haemopoietic and lymphatic
neoplasms, the Boxer headed the list (3.9)
with the Bassett Hound (3.6) and the St.
Bernard (3 3) very close.
In cats the R value for haemopoietic
neoplasms was 4-5 in the Manx breed and 341
in Burmese.
The monograph provides a mass ofinterest-
ing observations and is excellent value at
$8.50.
L. N. OWEN
Interferon 2. Ed. GRESSER (1980). London:
Academic Press. 95 pp. £6.80.
Following the successful first volume in
1979, this book will have been enthusiastically
awaited by specialists in several fields, not
only because it succeeds in bringing together
between the same covers diverse aspects of
current interferon research, but also because
this research is advancing with quite excep-
tional rapidity simultaneously on all fronts.
Knight deals in the first chapter with theBOOK REVIEWS
purification and characterization ofthe inter-
ferons, without actually telling us how these
were achieved, and delineates properties of
homogeneous human and mouse interferons
(anti-tumour activity and modulation of
immune response), long since inferred from
partially purified preparations. This will be
gratifying to those who have yet to gain
access to the pure materials for their work.
Taylor-Papadimitriou deals with the effects
of interferons on cell growth and function.
This chapter is rather more demanding on
the reader, and although somewhat repeti-
tive of articles by Stewart, Friedman and
Revel which appeared in Volume 1, is
nevertheless a cogent distillation of present
information on this topic.
The chapter by Burke on the interferon-
alpha gene system, its chromosomal location
and control of expression epitomises the aim
of this series, which is to render the recent
and often complex advances in one disci-
pline digestible to specialists in others. This
chapter succeeds admirably and the role of
chromosomes 9, 2 and 5 is lucidly expounded.
On the problems of purifying lympho-
blastoid interferon on a preparative scale for
clinical use, the ensuing chapter by Finter
and Fantes is a pragmatic appraisal of the
problems encountered in recent years and the
painstaking efforts to resolve them.
The last chapter on lymphokines, cytokines
and interferons, despite the eminence of its
contributors (Cohen and Bigazzi) is really
too brief to be useful, and unfortunately
does not bear comparison with other recent
reviews in the lymphokine field.
An important aspect of the book is the
Report from the Committee on Interferon
Nomenclature (Chairman, W. E. Stewart, II).
The reclassification of interferon on the basis
of antigenic specificities is discussed. The
type designations of, 8 and y, replace the
previous designations of leucocyte, fibro-
blast (Type I) and Type 1I (immune) inter-
ferons, respectively, and all investigators are
urged to adopt the new nomenclature.
Schemes for the designation of subtypes
of each of the major interferon types will
be determined at future meetings of the
Committee.
M. MOORE
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